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Abstract
Immune cell infiltration of expanding adipose tissue during obesity and its role in insulin resistance has been described and
involves chemokines. However, studies so far have focused on a single chemokine or its receptor (especially CCL2 and CCL5)
whereas redundant functions of chemokines have been described. The objective of this work was to explore the expression
of chemokines in inflamed adipose tissue in obesity. Human and mouse adipocytes were analyzed for expression of
chemokines in response to inflammatory signal (TNF-a) using microarrays and gene set enrichment analysis. Gene
expression was verified by qRT-PCR. Chemokine protein was determined in culture medium with ELISA. Chemokine
expression was investigated in human subcutaneous adipose tissue biopsies and mechanism of chemokine expression was
investigated using chemical inhibitors and cellular and animal transgenic models. Chemokine encoding genes were the
most responsive genes in TNF-a treated human and mouse adipocytes. mRNA and protein of 34 chemokine genes were
induced in a dose-dependent manner in the culture system. Furthermore, expression of those chemokines was elevated in
human obese adipose tissue. Finally, chemokine expression was reduced by NF-kB inactivation and elevated by NF-kB
activation. Our data indicate that besides CCL2 and CCL5, numerous other chemokines such as CCL19 are expressed by
adipocytes under obesity-associated chronic inflammation. Their expression is regulated predominantly by NF-kB. Those
chemokines could be involved in the initiation of infiltration of leukocytes into obese adipose tissue.
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Introduction
Obesity, which can be defined as an excess of body fat mass, is a
major risk for developing type 2 diabetes caused from the systemic
insulin resistance. Obesity-induced insulin resistance is believed to
result initially from adipose tissue expansion and hypoxia response
[1], which leads to the release of free fatty acids (FFAs) into the
circulation as well as inducing adipocyte apoptosis or necrosis. On
the long term, elevated plasma FFAs contributes to skeletal muscle
insulin resistance and augments hepatic glucose production. The
importance of adipose tissue has been confirmed by showing that
gastric bypass-induced weight loss or surgical removal of excess fat
can restore insulin sensitivity in animals and humans [2,3].
Furthermore, works from Hotamisligil et al. [4] have shown that
adipose tissue derived inflammatory mediator Tumor Necrosis
Factor-a (TNF-a) is involved in obesity-associated insulin
resistance, leading to the ‘‘inflammation theory’’ that suggests
that obesity and type 2 diabetes are inflammatory diseases. It has
been shown that TNF-a expression is increased in the adipose
tissue of obese individuals [4], that its level is correlated with
adiposity [5] and numerous studies have highlighted TNF-a
involvement in the etiology of insulin resistance [6]. The exact
origin of TNF-a remained undetermined until Weisberg et al. and
Xu et al. shown that macrophages are infiltrating into adipose
tissue in obesity and that macrophages are the major source of
TNF-a [7,8]. These observations greatly enriched the inflamma-
tion theory and this finding opened a field of intense research
about immune cell infiltration in the adipose tissue.
Macrophage infiltration has been by far the most investigated in
obesity, and several groups have studied the role of chemokines
(chemoattractant cytokines) such as CCL2/MCP-1 (C-C motif
chemokine ligand 2/macrophage chemoattractant protein-1).
These studies have shown that inhibition of CCL2 by gene
knockout or chemical blockade is able to diminish macrophage
infiltration, but unable to block it completely [9,10,11,12,13,14],
suggesting that other chemokines might be involved in this
process. In support of this view, studies have shown that several
other chemokines such as CCL5 [15], C-X-C motif chemokine
ligand 5 (CXCL5 [16]) and CXCL14 [17] are all involved in
adipose macrophage infiltration and pathogenesis of insulin
resistance. Again, individual inhibition of the chemokines was
not sufficient to completely restore insulin sensitivity.
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Actually, almost all types of immune cells (lymphocytes,
neutrophils, monocytes/macrophages, dendritic cells, natural
killer cells) are infiltrating obese adipose tissue during obesity
development [18] and contribute to the pathogenesis of insulin
resistance. These studies suggest that insulin resistance generated
by obese adipose tissue infiltration relies on several cell types and
hence several chemokines. Although the initial event(s) leading to
leukocyte infiltration and the exact sequence of infiltration of the
different immune cell types remain to be fully established yet, it
appears that B cells, T cells and neutrophils would infiltrate at the
early stages of adipose tissue expansion, whereas macrophage
infiltration would rather happen at the late stages of adipose tissue
expansion [19], and contribute to the sustained chronic inflam-
mation [20]. This suggests that adipose infiltration of multiple
immune cells is a programmed event. It may be dependent on a
network of chemokines, the nature of which remains to be
determined.
In this paper, we describe that adipocytes are able to express 34
chemokines involved in the attraction of most immune cells.
Furthermore, the role of adipocytes has been confirmed in vivo, by
measuring chemokine expression in adipose tissue from obese
subjects, and we demonstrate that chemokine expression is
predominantly regulated via the Nuclear Factor-kB (NF-kB)
pathway using chemical inhibitors and transgenic models.
Materials and Methods
Reagents
Dulbecco’s modified Eagle’s medium (DMEM) was purchased
from Life Technologies (Cergy Pontoise, France), and fetal bovine
serum (FBS) was obtained from PAA Laboratories (Les Mureaux,
France). Isobutylmethylxanthine, dexamethasone and insulin were
purchased from Sigma-Aldrich (Saint Quentin Fallavier, France).
TRIzol reagent, random primers and Moloney murine leukemia
virus reverse transcriptase were obtained from Life Technologies.
SYBR Green reaction buffer was purchased from Eurogentec
(Angers, France). Antibodies were purchased from eBiosciences
SAS (Paris, France). Unless otherwise specified, all other reagents
were purchased from Sigma-Aldrich.
Cell Culture
3T3-L1 preadipocytes (ATCC, Manassas, VA) were seeded in
3.5-cm diameter dishes at a density of 156104 cells/well, and
grown in DMEM supplemented with 10% FBS, at 37uC in a 5%
CO2 humidified atmosphere, as previously reported [21]. To
induce differentiation, two-day postconfluent 3T3-L1 preadipo-
cytes (day 0) were stimulated for 48 h with 0.5 mM isobutyl-
methylxanthine, 0.25 mmol/l dexamethasone and 1 mg/ml insulin
in DMEM supplemented with 10% FBS. The cultures were then
treated with DMEM supplemented with 10% FBS and 1 mg/ml
insulin. Then, adipocytes were incubated with TNF-a (15 ng/ml)
for 24 h.
Human preadipocytes (isolated from female subcutaneous
adipose tissue biopsies) were supplied by Promocell (Heidelberg,
Germany), cultured and differentiated into adipocytes according
to the company’s instructions. Briefly, cells were seeded at a
density of 5000 cells/cm2 in Preadipocyte Growth Medium and
grown until confluence was reached. Cells were then allowed to
differentiate for 3 days in Preadipocyte Differentiation Medium
and mature adipocytes were cultivated in Adipocyte Nutrition
Medium for 11 additional days. Adipose maturity was assessed at
the morphological (light microscopy) and the genomic expression
levels (comparison of expression level of pre-adipocyte (Pref-1) and
adipocyte markers - CEBPA, aP2, and ADIPOQ -, Figure S1.
In a first series of experiments, mature adipocytes (day 14)
were incubated for 24 h with 5–15 ng/ml of TNF-a. In order
to identify which pro-inflammatory pathway was involved in
TNF-a chemokine expression, mature human adipocytes were
pre-incubated for 1 h with either 20 mM JNK-inhibitor-II,
20 mM SB 202190, or 10 mM BAY 11-7082 (c-Jun NH2-
terminal Kinase – JNK –, p38 mitogen activated protein –
MAP – kinase and NF-kB pathway inhibitors, respectively, all
obtained from Merck Millipore, Darmstadt, Germany). The
medium containing the inhibitor was then aspired; cells were
rinsed with PBS and then incubated for 24 h with 15 ng/ml
TNF-a in culture medium.
NF-kB p65 null Mouse Embryonic Fibroblasts (MEFs) were
obtained from Dr. Inder M. Verma (Salk Institute). The cells were
maintained in DMEM cell culture medium supplemented with
10% fetal bovine serum. The cells were treated with TNF-a
(20 ng/ml) in serum free medium containing 0.25% BSA for 2 h
and total RNA was extracted using TRIzol reagent as described
below.
Hybridization Arrays and Microarray Data Analysis
RNA quality control was performed on an Agilent 2100
Bioanalyzer (Massy, France) with 6000 Nano Chips, according to
the manufacturer’s instructions. For human adipocytes and 3T3-
L1 cells, six independent cultures were grown in quadruplicate (i.e.
24 controls and 24 TNF-a treated). RNAs were hybridized to
Agilent Whole Human Genome (4644 k; Massy, France). All
labeling, hybridization, washing and scanning were performed as
described in the manufacturer’s protocol and as previously
described [22]. Arrays were scanned with an Agilent Scanner
(Massy, France). Data were extracted with Agilent Feature
Extraction v10.5.1.1 and analyzed with Agilent GeneSpring GX
v11.0.2 (Massy, France). Data were normalized according to the
locally weighted scatterplot smoothing (LOWESS) method, and
multiple correction test false discovery rate was applied. Further
analyses were performed with Gene Set Enrichment Analysis
(GSEA) software (http://www.broadinstitute.org/gsea). A False
Discovery Rate (FDR) q-value ,0.25 for normalized enrichment
score was considered significant.
RNA Isolation and qPCR
Total cellular RNAs were extracted using TRIzol reagent
according to the manufacturer’s instructions. cDNAs were
synthesized from 1 mg of total RNA using random primers and
Moloney murine leukemia virus reverse transcriptase. Real-time
quantitative RT-PCR analyses were performed using the
Mx3005P Real-Time PCR System (Stratagene, La Jolla, CA) as
previously described [23]. For each condition, expression was
quantified in duplicate and 18S rRNA was used as the endogenous
control in the comparative cycle threshold (CT) method. Data
were expressed as relative expression ratio. The sequences of the
primers and Taqman gene expression assays (Applied Biosystems)
used for qPCR determination of gene expression are displayed in
Table S1.
Chemokine Determination in Culture Medium
CCL2 was quantified with the human CCL2 (MCP-1) Ready-
SET-Go!H ELISA from eBiosciences. A Milliplex assay (Millipore,
Molsheim, France) was used to quantify CCL5, Interleukin-6 (IL-
6), CXCL1, CXCL8 and CXCL10 in human adipocyte culture
medium with the Luminex 100H platform.
Chemokine Expression in Obese Adipose Tissue
PLOS ONE | www.plosone.org 2 June 2013 | Volume 8 | Issue 6 | e66515
Human White Adipose Tissue Biopsies
Eleven lean (Body Mass Index: 22.560.5 kg/m2) and fourteen
obese (BMI: 31.760.9 kg/m2) male subjects were recruited for this
study. Lean and obese volunteers were aged 4467 years and
4465 years, respectively. Subcutaneous adipose tissue biopsies
were performed between 6:30 a.m. and 7:30 a.m. after an
overnight fast. Biopsies were obtained by needle aspiration in
the periumbilical area under local anesthesia. Adipose tissue
samples were rinsed in physiologic serum, immediately frozen in
liquid nitrogen and stored at 280uC until RNA extraction. The
experimental protocol was performed in accordance with the
guidelines in the Declaration of Helsinki and was approved by the
Ethical Committee of the Auvergne region (agreement no. AU
800; March 2010). Participants provided their written informed
consent to participate in this study.
Animal Experiments
aP2-p65 mice were generated on the C57BL/6J background as
described elsewhere [24]. All of the mice were housed in the
animal facility at the Pennington Biomedical Research Center
with a 12:12-h light-dark cycle and constant temperature (22–
24uC). The male mice were fed chow diet (MF 5001, 11% calorie
in fat) and the epididymal fat tissue was collected at 20 weeks. The
mice were housed at 4 per cage with free access to water and diet.
All procedures were performed in accordance with the National
Institutes of Health guidelines for the care and use of animals and
were approved by the Institutional Animal Care and Use
Committee (IACUC) at the Pennington Biomedical Research
Center.
Results
TNF-a Induces Chemokine Expression in Adipocytes
Human adipocyte primary cultures were subjected to TNF-a
treatment (15 ng/ml) for 24 h after which total RNA was
extracted for gene expression analysis using microarrays. Results
were validated by qPCR (table S2) of randomly chosen genes, as
well as genes whose expression were known to be affected by TNF-
a (e.g. ADIPOQ, IRS1 and PPARG). Examination of the gene list
indicated that several chemokine genes were among the most
dramatically upregulated in response to TNF-a: indeed, expres-
sion of 34 chemokines were found to be significantly modulated,
with CCL5, CCL19 and CCL20 being the most dramatically
affected (Table 1). Gene Set Enrichment Analysis (GSEA)
according to gene ontology terms confirmed that chemokines
were the most overrepresented genes, and highlighted inflamma-
tion related processes such as defense response, locomotory
behavior and chemokine activity as the most represented terms
(the first 10 most represented gene sets are displayed on Table S3).
Furthermore, chemokine expression was found to be dose
dependent (Table 1). Interestingly, very similar results were
obtained when murine 3T3-L1 differentiated in adipocytes were
treated (supplemental tables S4 and S5).
A parallel increase in protein secretion in culture medium was
investigated for a subset of these chemokines (Figure 1). Again,
CCL5 was found to be the most significantly induced protein,
being undetectable in non stimulated adipocytes, and reaching a
concentration of around 2000 pg/ml after 24 h of TNF-a
treatment. CXCL8 and CXCL10 levels were also dramatically
increased (by 98.0 and 376.3 fold, respectively) in response to
TNF-a. CCL2, CXCL1 and IL-6 secretion were also increased in
the culture medium, but to a lesser extent.
Chemokine Expression is Upregulated in the Adipose
Tissue of Obese Individuals
To confirm our observations, chemokine expression was
investigated in subcutaneous adipose tissue of obese and lean
subjects (Figure 2). A significant increase in expression was
observed in most of the genes investigated: CCL2, CCL5, CCL7,
CCL19, CXCL1, CXCL5, CXCL8 and CXCL10 were increased by
2.5, 2.7, 1.9, 6.3, 2.5, 3.0, 3.4 and 2.0 fold, respectively, in obese
subjects vs. controls. CCRL1 (C-C motif chemokine receptor-like 1)
and CXCL2, albeit being overexpressed in response to TNF-a
in vitro had their level unchanged in obese adipose tissue.
Surprisingly, CX3CL1 (C-X3-C motif ligand 1) expression was
found to be 1.7 fold lower in obese subjects (Figure 2).
Additionally, we observed that TNF expression was higher in
the adipose tissue of obese subjects, and was significantly
correlated with the expression of CCL2, CCL5, CCL7, CXCL1,
CXCL2 and CXCL8 (Table 2).
TNF-a Induced Chemokine Expression is Mediated by NF-
kB
To unravel the molecular mechanisms underlying chemokine
expression in adipocytes, we analyzed the microarray data with
GSEA again, but this time according to transcription factor
binding site overrepresentation (Table S6). Interestingly, we found
that NF-kB binding site as the most enriched response element,
which is fully consistent with the fact NF-kB plays a central role in
the regulation of inflammatory response and is known to be
activated by TNF-a [25]. Similar data were obtained for TNF-a -
treated 3T3-L1 cells (Table S7). Furthermore, similarly to what
Ruan et al. [26] reported in 3T3-L1 cells, we observed an increase
in mRNA levels of several members of the NF-kB family such as
NFKB1 (63.2), NFKB2 (65.8), RELA (61.6), RELB (69.9) and
associated regulatory proteins such as inhibitor of kappa light
polypeptide gene enhancer in B-cells, kinase beta, IKBKB (61.3),
IKBKE (64.4), IKBKG (61.1) and B-cell CLL/lymphoma 3, BCL3
(62.5) following TNF-a treatment.
These data reinforce the putative major role of NF-kB in the
regulation of chemokine expression under these conditions.
To confirm the involvement of NF-kB in the regulation of
chemokine expression in vivo, we took advantage of a murine
model in which the p65 gene, encoding the transcriptional activity
of NF-kB, has been overexpressed (Figure 3). The expression of all
chemokines assessed by qPCR was found to be increased in the
white adipose tissue of aP2-p65 mice by at least 9.5-fold, with Ccl5
and Ccl19 being increased by around 40-fold. Ccl20 mRNA was
detected in the adipose tissue of aP2-p65 mice only, with a mean
CT value of 29.5.
The implication of NF-kB was then assessed in p65 null MEFs:
basal chemokine expression in untreated cells was always lower in
p65 null MEFs than in wild-type cells, suggesting that NF-kB is
involved in the constitutive expression of these chemokines
(Figure 4). On the other hand, TNF-a treatment of WT MEF
cells resulted in the upregulation of Tnf, Il6 and chemokine mRNA
expression by at least 3.5 fold (except Ccl19 which could not be
detected, Figure 4). As expected, no statistically significant
induction could be observed in p65 null cells in response to
TNF-a, and Tnf and Ccl20 expression became undetectable.
These data indicate that NF-kB is the main mediator of
chemokine expression in response to TNF-a. Still, a noticeable but
non significant induction was observed for Cxcl1, Cxcl10 and
Cx3cl1 in response to TNF-a in p65 null MEF cells. This
observation suggests that there might be an alternative signaling
pathway mediating TNF-a induced chemokine expression.
Chemokine Expression in Obese Adipose Tissue
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Table 1. List of chemokine related genes significantly regulated (p,0.01) by TNF-a treatment in human adipocytes.
mRNA induction (fold change vs.
control)
Gene
symbol Array Probe Description
TNF-a
5 ng/ml
TNF-a
10 ng/ml
TNF-a
15 ng/ml
CCL1 A_23_P49759 Homo sapiens chemokine (C-C motif) ligand 1 (CCL1), mRNA [NM_002981] 3.6
CCL13 A_24_P125335 Homo sapiens chemokine (C-C motif) ligand 13 (CCL13), mRNA [NM_005408] 5.1
A_23_P26965 5.2
CCL17 A_23_P26325 Homo sapiens chemokine (C-C motif) ligand 17 (CCL17), mRNA [NM_002987] 2.6 2.9 4.5
CCL19 A_23_P123853 Homo sapiens chemokine (C-C motif) ligand 19 (CCL19), mRNA [NM_006274] 31.6 46.5 149.9
CCL2 A_23_P89431 Homo sapiens chemokine (C-C motif) ligand 2 (CCL2), mRNA [NM_002982] 10.5 11.5 23.6
CCL20 A_23_P17065 Homo sapiens chemokine (C-C motif) ligand 20 (CCL20), mRNA [NM_004591] 25.6 35.8 145.5
CCL25 A_23_P55828 Homo sapiens chemokine (C-C motif) ligand 25 (CCL25), mRNA [NM_005624] 1.4
CCL28 A_23_P503072 Homo sapiens chemokine (C-C motif) ligand 28 (CCL28), mRNA [NM_148672] 1.8
CCL5 A_23_P152838 Homo sapiens chemokine (C-C motif) ligand 5 (CCL5), mRNA [NM_002985] 49.0 64.1 344.8
CCL7 A_23_P78037 Homo sapiens chemokine (C-C motif) ligand 7 (CCL7), mRNA [NM_006273] 3.9 4.5 4.8
CCL8 A_23_P207456 Homo sapiens chemokine (C-C motif) ligand 8 (CCL8), mRNA [NM_005623] 18.8 26.7 26.0
CMKLR1 A_23_P105465 Homo sapiens chemokine-like receptor 1 (CMKLR1), mRNA [NM_004072] 23.6 24.1 23.7
A_23_P105461 210.2 28.9 212.8
A_24_P766716 214.1 218.7 221.8
CCR1 A_24_P148717 Homo sapiens chemokine (C-C motif) receptor 1 (CCR1), mRNA [NM_001295] 23.0 22.0 22.7
CCR7 A_23_P343398 Homo sapiens chemokine (C-C motif) receptor 7 (CCR7), mRNA [NM_001838] 1.3
CCRL1 A_23_P6909 Homo sapiens chemokine (C-C motif) receptor-like 1 (CCRL1), transcript variant 1, mRNA
[NM_178445]
23.1 23.7 24.4
CCRL2 A_23_P69310 Homo sapiens chemokine (C-C motif) receptor-like 2 (CCRL2), mRNA [NM_003965] 2.1
CX3CL1 A_24_P381901 Homo sapiens chemokine (C-X3-C motif) ligand 1 (CX3CL1), mRNA [NM_002996] 3.6
A_24_P390495 5.5 10.0 34.0
A_23_P37727 19.1 34.4 87.8
CXCL1 A_23_P7144 Homo sapiens chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity,
alpha) (CXCL1), mRNA [NM_001511]
14.8 17.1 35.3
CXCL10 A_24_P303091 Homo sapiens chemokine (C-X-C motif) ligand 10 (CXCL10), mRNA [NM_001565] 12.4 17.6 34.0
CXCL11 A_24_P20607 Homo sapiens chemokine (C-X-C motif) ligand 11 (CXCL11), mRNA [NM_005409] 6.3 7.7 32.2
A_23_P125278 21.1 37.8 113.9
CXCL12 A_23_P202448 Homo sapiens chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) (CXCL12),
transcript variant 1, mRNA [NM_199168]
2.3 2.0
A_24_P944054 4.5 3.3 1.8
A_24_P412156 5.2 4.0 3.4
CXCL13 A_23_P121695 Homo sapiens chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) (CXCL13),
mRNA [NM_006419]
10.8
CXCL14 A_23_P213745 Homo sapiens chemokine (C-X-C motif) ligand 14 (CXCL14), mRNA [NM_004887] 3.4
CXCL16 A_23_P38505 Homo sapiens chemokine (C-X-C motif) ligand 16 (CXCL16), mRNA [NM_022059] 1.4
CXCL2 A_23_P315364 Homo sapiens chemokine (C-X-C motif) ligand 2 (CXCL2), mRNA [NM_002089] 14.1 15.1 15.3
A_24_P257416 5.7 6.4 12.1
CXCL3 A_24_P183150 Homo sapiens chemokine (C-X-C motif) ligand 3 (CXCL3), mRNA [NM_002090] 15.1 16.7 32.4
A_24_P251764 3.2 3.2 5.6
CXCL5 A_23_P110204 Homo sapiens chemokine (C-X-C motif) ligand 5 (CXCL5), mRNA [NM_002994] 22.9 27.7 24.0
A_24_P277367 9.5 10.7 11.0
CXCL6 A_23_P155755 Homo sapiens chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2)
(CXCL6), mRNA [NM_002993]
32.1 38.2 53.8
CXCL8 A_32_P87013 Homo sapiens interleukin 8 (IL8), mRNA [NM_000584] 22.8 24.6 70.8
CXCL9 A_23_P18452 Homo sapiens chemokine (C-X-C motif) ligand 9 (CXCL9),
mRNA [NM_002416]
5.1
CXCR2 A_23_P135755 Homo sapiens chemokine (C-X-C motif) receptor 2 (CXCR2), transcript variant 1, mRNA
[NM_001557]
21.9
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Finally, to investigate the possible involvement of other signaling
pathways in TNF-a induced chemokine expression in adipocytes,
we preincubated cells with chemical inhibitors of p38, JNK or NF-
kB before performing TNF-a stimulation (15 ng/ml). The
expression level of CCL2, CCL5 and CXCL10 was then measured
using qPCR. While p38 chemical blockade did not modify
chemokine expression in response to TNF-a (data not shown),
JNK inhibition led to a decrease in CCL5 and CXCL10
expression, whereas CCL2 level was not affected (Figure 5).
Finally, inhibition of the NF-kB pathway totally suppressed
chemokine expression in response to TNF-a.
Altogether, these results clearly indicate that NF-kB is the
central regulator of chemokine expression in response to TNF-a.
Discussion
Obesity is associated with an increased risk of type 2 diabetes or
cardiovascular diseases. Studies over the past 10 years have
highlighted the role of inflammatory mediators secreted by the
adipose tissue (such as chemokines and cytokines) in the incidence
of systemic insulin resistance [27]. Although adipose tissue
inflammation is related to infiltration of multiple immune cells,
the underlying mechanism is largely unknown. In this study, we
addressed this question by investigating chemokine network in
adipocytes and adipose tissue.
Chemokines are defined as ‘‘cytokines with selective chemoat-
tractant properties’’, coordinating the leukocyte movement to sites
of inflammation or injury [28]. The chemokine system, which
comprises around 50 ligands and 20 receptors, is characterized by
its redundancy [29], i.e. some chemokines share a common
receptor, and most receptors are able to interact with several
ligands. So far, only a few chemokines have been investigated for
their role in obesity for leukocyte infiltration, and several
chemokines have been reported in the etiology of obesity-
associated inflammation and insulin resistance [9,11,15,16,17].
Whereas most of the attention is focused on CCL2/MCP-1 (refs
10, 32), it is however noteworthy that knockout or blocking of
CCL2 or CCR2 failed (when having any effect) to completely
suppress macrophage infiltration into adipose tissue or fully to
restore insulin sensitivity [9,13,14,30]. Similar modest effects have
also been observed in intervention of chemokines such as CCL3,
CXCL5, or CXCL14 (refs 16, 17, 34). This group of studies
Table 1. Cont.
mRNA induction (fold change vs.
control)
Gene
symbol Array Probe Description
TNF-a
5 ng/ml
TNF-a
10 ng/ml
TNF-a
15 ng/ml
DARC A_23_P115161 Homo sapiens Duffy blood group, chemokine receptor (DARC), mRNA [NM_002036] 1.4
FAM19A2 A_24_P297551 Homo sapiens family with sequence similarity 19 (chemokine (C-C motif)-like), member A2
(FAM19A2), mRNA [NM_178539]
22.7
FAM19A5 A_23_P304489 Homo sapiens family with sequence similarity 19 (chemokine (C-C motif)-like), member A5
(FAM19A5), transcript variant 2, mRNA [NM_015381]
22.1 22.2 21.8
doi:10.1371/journal.pone.0066515.t001
Figure 1. TNF-a induces chemokine secretion in the culture medium of human adipocytes. Cells were incubated for 24 h with TNF-a
(15 ng/ml). White diagrams represent the control value and black diagram the TNF-a treatment value. Data are shown as mean 6 SEM of 6
independent experiments. n.d.: not detected.
doi:10.1371/journal.pone.0066515.g001
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strongly suggests that other chemokines might compensate the loss
of one chemokine in these models and that the chemokine network
have to be taken into account when studying immune cell
infiltration in the adipose tissue. In agreement with this
assumption, the ability of subcutaneous adipose tissue to express
multiple chemokine ligands and receptors has been reported in
humans [31,32,33,34]. In addition, in the present study we showed
in vitro that human adipocytes are able to express and probably
secrete a large range of chemokines (Table 1, Figure 1).
Furthermore, the fact that very similar observations were obtained
with the 3T3-L1 cell line rules out the possibility of a significant
contribution from other cell types to chemokine expression in
human primary cultures. Altogether, these data support that
adipocytes produce a range of chemokines and are important to
determine the function of chemokine network in the adipose tissue.
Finally, we demonstrated that expression of these chemokines is
elevated in obese condition in subcutaneous adipose tissue
(Figure 2), which is in agreement with previous observations from
Dahlman et al. [10] and Huber et al [32]. However, it should be
noted that the most upregulated genes in response to TNF-a
in vitro (i.e. CCL5, CCL19 and CCL20) are not the ones that are
overexpressed in obese vs. lean subjects. Discrepancies between
the results observed in cell culture and adipose tissue biopsies
could arise from 1) methodological aspects: in cell culture only
adipocytes were present whereas biopsies also contain other cell
types in which gene regulation might be different to what is
occurring in adipocytes and therefore could dilute or mask gene
regulation in the adipocyte fraction. Furthermore, gene expression
results were generated using microarrays in the case of adipocytes
whereas qPCR was used to compare chemokine expression
between obese and lean adipose tissue, which makes the
comparison of data in terms of fold change impossible. 2)
biological aspects: the in vitro experiment is an acute inflamma-
tory signal (24 h) whereas in the obese biopsies low grade
inflammation might have been present for years. Hence, the
in vitro experiment might reflect the early phases of chemokine
expression by adipocytes whereas in vivo data should be regarded
as the chemokine expression pattern resulting from established
obesity (probably several years).
If the exact origin of leukocyte infiltration remains elusive
(although it has been proposed to result from ceramide production
due to excess lipid intake leading to subsequent TNF-a synthesis
[35], the chronology of adipose tissue infiltration by leukocytes
would first see the arrival of neutrophils, B cells and T cells before
monocytes/macrophages [36]. Of interest regarding the initiation
of adipose tissue infiltration, CXCL1, CXCL3, CXCL5, CXCL6,
and CXCL8 are known to be able to mediate the recruitment of
neutrophils (through binding to CXCR1 and/or 2 [28]), which
would be the earliest type of leukocytes detected in adipose tissue
in response to high fat feeding in mice [37]. Furthermore, the
involvement of CXCL5 in adipose tissue macrophage infiltration
and muscle insulin resistance has already been described [16].
Microarray data also revealed that CCL19 and CCL20 were among
the most upregulated genes. Interestingly, these are ligands of the
CCR7 and CCR6 receptors [28], respectively, and are expressed
by B lymphocytes. Since B cells are also detected early in the
adipose tissue of HFD fed animals [36] and have been proposed as
important players in insulin resistance development [38], this
strengthens the idea that adipocytes could be primers of the
adipose tissue inflammation. Furthermore, CCL20 is able to
attract Th17 cells, whose implication is increasingly studied in
pathological inflammation states through their ability to secrete
the pro-inflammatory cytokine IL17 [39]. Duffaut et al. reported
that CCL20 expression is associated with BMI, is elevated in
Table 2. Correlation between TNF and chemokine expression levels in human adipose tissue.
Gene CCL2 CCL5 CCL7 CCL19 CCRL1 CXCL1 CXCL2 CXCL5 CXCL8 CXCL10 CX3CL1
Ra 0.740 0.686 0.612 0.168 20.037 0.782 0.454 0.117 0.338 0.460 20.230
P value ,0.001 ,0.001 ,0.001 0.244 0.797 ,0.001 0.001 0.427 0.016 0.001 0.108
aPearson correlation coefficient, N = 25.
doi:10.1371/journal.pone.0066515.t002
Figure 2. Chemokine expression is increased in obese adipose tissue from obese subjects. Chemokine mRNA expression levels were
analyzed by qPCR. Data are shown as mean 6 SEM, (N = 11–14 volunteers/group). t-test significance: *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0066515.g002
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adipocytes from obese subjects and mediates lymphocyte migra-
tion [31]. We also found that CCL19 expression is increased in
human adipose. To our knowledge, this is the first time that this
gene is reported for being overexpressed in obese adipose tissue.
The role of infiltrated T cells in the generation of insulin
resistance is also increasingly studied [40]. Interestingly, among
the most overexpressed chemokines highlighted in our study,
several of them are able to promote the attraction of Th1 (pro-
inflammatory) cells (i.e. CXCL10-11 via CXCR3 binding, CCL5
and CCL8 via CCR5, CCL19 via CCR7 and CX3CL1 via
binding to CX3CR1). Similar data were observed in vivo for
CCL5, CCL19 and CXCL10 in obese adipose tissue (Figure 2).
Finally, human adipocytes were found to strongly express
chemokines able to stimulate monocyte attraction in response to
TNF-a, especially CXCL1-3, 5–6, 8, and 10–11, which are
ligands for CXCR1 and/or 2, but also CCL2 via CCR2, CCL5
via CCR1 or CCR5, CCL8 via CCR or CCR5 binding and
CX3CL1 via CX3CR1 binding [28]. In line with previous reports
[15,32], CCL2 and CCL5 were also more expressed in obese
compared to lean adipose tissue (Figure 2). Elevated circulating
levels of CX3CL1 (fractalkine) have been recently reported in type
2 diabetes subjects [41]. Even though CX3CL1 expression was
found to be regulated by TNF-a in human adipocytes, its
expression decreased in the adipose tissue of obese vs. lean
volunteers (Figure 2). Whereas Shah et al. showed that CX3CL1
Figure 4. Chemokine expression in response to TNF-a is highly dependent on p65 NF-kB activity. Gene expression was measured by
qPCR in WT or p65 null MEFs treated or not with TNF-a (mean 6 SEM of 4–5 independent experiments). n.d.: not detected, values sharing a different
letter are statistically different at p,0.05 (one-way ANOVA followed by Tukey-Kramer post hoc test).
doi:10.1371/journal.pone.0066515.g004
Figure 3. Chemokine expression is induced in the adipose
tissue of aP2-p65 mice. Chemokine expression levels were compared
with that of WT animals (mean 6 SEM, N= 3 animals/group). t-test
significance: *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0066515.g003
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was more expressed in visceral vs. subcutaneous fat [41], to our
knowledge no data are available regarding its expression in human
subcutaneous obese vs. lean subjects. It is therefore possible that
CX3CL1, even if regulated by TNF-a in vitro, is not differently
expressed in the subcutaneous adipose tissue of obese and lean
individuals. The origin of this discrepancy will require further
experiments.
TNF-a secretion is central in maintaining obesity driven
inflammatory loop as it is produced by infiltrated leukocytes from
the stromal fraction [42], and we found that its expression level in
adipose tissue was correlated with those of many chemokines in
adipose tissue biopsies (Table 2). In our in vitro experiments,
TNF-a was used to mimic mild inflammatory conditions, as
described previously [43]. To find out how TNF-a regulates
chemokine expression we ran GSEA analysis of the microarray
data, which indicated NF-kB as the main response element present
in the overrepresented genes (Table S6). Then, to confirm
experimentally the involvement of NF-kB in the regulation of
chemokines, we used 2 transgenic models: adipose tissue from aP2-
p65 overexpressing mice (Figure 3), and MEFs invalidated for p65
gene (Figure 4), the latter being treated or not with TNF-a. All
chemokine genes were overexpressed in aP2- p65 adipose tissue
and lost their TNF-a dependent expression in p65-null cells.
However, the existence of a residual albeit non significant gene
induction following TNF-a treatment was observed for Cxcl1,
Cxcl10 and Cx3cl1 in p65 null MEFs. This effect could be
explained by the fact that TNF-a is also able to mediate its pro-
inflammatory effects, besides NF-kB, via another signaling
pathways such as p38 or JNK. Indeed, pretreatment of adipocytes
with a JNK inhibitor before TNF-a treatment reduced CCL5 and
CXCL10 expression in human adipocytes whereas inhibition of
NF-kB completely suppressed TNF-a chemokine upregulation
(Figure 5). Our results are in agreement with studies from Jiao and
colleagues, who identified six CCLs (i.e. CCL2, CCL3, CCL6,
CCL7, CCL8 and CCL9) upregulated in the adipose tissue of
HFD induced and genetically obese mice [44]. They observed that
FFAs could induce the expression of these chemokines in 3T3-L1
adipocytes and that JNK inhibition could only limit the expression
of MCP-1/CCL2 and MCP-3/CCL7 whereas NF-kB inhibition
was able to repress the expression of all the chemokines tested.
These data are similar to what we observed in TNF-a treated
adipocytes and support the fact that NF-kB is the major regulator
of chemokine expression in response to pro-inflammatory mole-
cules even if redundant signalling pathways could also participate.
In conclusion, our results show that adipocytes are intrinsically
able to initiate adipose tissue infiltration by all subtypes of
leukocytes through the secretion of multiple chemokines under the
effect of TNF-a, via a NF-kB dependent pathway. Also, the high
number of chemokines induced (most of which have redundant
properties) supports the fact that leukocyte adipose tissue
infiltration observed during obesity is not related to one or two
proteins such as CCL2 or CCL5. We propose that less ‘classical’
chemokines should be investigated for their role in the develop-
ment of insulin resistance through recruitment of leukocytes in the
adipose tissue and their use as alternative or more sensitive
markers of infiltration. In particular, it would be of interest to
investigate in more details the role of CCL19, as the expression
level of this chemokine in adipocytes was found to be highly
sensitive to TNF-a as well as adiposity.
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